Citi Upgrades Integer Holdings (ITGR) to Buy, Lifts PT

On May 22, Citi analysts upped Integer Holdings Corporation (NYSE:ITGR)’s stock from “Neutral” to “Buy,” increasing the price objective to $140 from $133.

The firm noted its healthy Q1 2025 performance, in which sales exceeded expectations. In Q1 2025, the company’s sales saw an increase of 7% to $437 million, with organic growth of 6%. Furthermore, segment growth met the expectations, with Cardio & Vascular seeing non-GAAP organic growth of 10.9% YoY.

After the successful start to the year, Integer Holdings Corporation (NYSE:ITGR)’s management expects YoY sales growth of 8% to 10% in 2025, which Citi analysts believe is conservative.

Citi saw that Integer Holdings Corporation (NYSE:ITGR) was largely unaffected by tariffs as it possesses minimal exposure to China and didn’t observe huge changes in the customer purchasing behavior. Given the company’s positioning in high-growth markets, along with its effective leadership transition, Citi believes that Integer Holdings Corporation (NYSE:ITGR) will accelerate progress moving forward.

The YoY growth in Cardio & Vascular sales in Q1 2025 stemmed from new product ramps in electrophysiology and acquisitions. This was partially offset by the impact of fewer shipping days in Q1 2025 as compared to Q1 2024.

Integer Holdings Corporation (NYSE:ITGR) operates as a medical device contract development and manufacturing company.

While we acknowledge the potential of ITGR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk.  If you are looking for an AI stock that is more promising than ITGR and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now

Disclosure: None.